YUHSpace: Dept. of Internal Medicine (내과학교실)

YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Internal Medicine (내과학교실)

Dept. of Internal Medicine (내과학교실)

Researcher List

Keyword Cloud

Journal Categories

Hot Articles

Trastuzumab in combination with chemotherapy versus chemotherapy alone f...

Yung-Jue Bang ; Eric Van Cutsem ; Andrea Feyereislova ; Hyun C Chung ; Lin Sh... LANCET, Vol.376(9742) : 687-697, 2010

Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer

Jean-Charles Soria ; Yuichiro Ohe ; Johan Vansteenkiste ; Thanyanan Reungwetw... NEW ENGLAND JOURNAL OF MEDICINE, Vol.378(2) : 113-125, 2018

Cetuximab and chemotherapy as initial treatment for metastatic colorecta...

Eric Van Cutsem ; Claus-Henning Köhne ; Erika Hitre ; Jerzy Zaluski ; Chung-R... NEW ENGLAND JOURNAL OF MEDICINE, Vol.360(14) : 1408-1417, 2009

PDF Read more

This table browses all dspace content
Issue Date	Title	Journal Title
2022	Left Ventricular Diastolic Dysfunction and Progression of Chronic Kidney Disease: Analysis of KNOW-CKD Data	JOURNAL OF THE AMERICAN HEART ASSOCIATION
2022	Prevalence and Characteristics of Atrial Tachycardia From Noncoronary Aortic Cusp During Atrial Fibrillation Catheter Ablation	KOREAN CIRCULATION JOURNAL
2022	Dll4 Inhibition Promotes Graft Retention in Fat Grafting Enriched with Adipose-Derived Stem Cells	STEM CELLS TRANSLATIONAL MEDICINE
2022	Endoscopic variceal obturation and retrograde transvenous obliteration for acute gastric cardiofundal variceal bleeding in liver cirrhosis	BMC GASTROENTEROLOGY
2022	Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial	GUT AND LIVER
2022	Neutralizing Activity Against SARS-CoV-2 Delta and Omicron Variants Following a Third BNT162b2 Booster Dose According to Three Homologous or Heterologous COVID-19 Vaccination Schedules	FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
2022	Long-term efficacy and safety of moderate-intensity statin with ezetimibe combination therapy versus high-intensity statin monotherapy in patients with atherosclerotic cardiovascular disease (RACING): a randomised, open-label, non-inferiority trial	LANCET
2022	Rapid prediction of in-hospital mortality among adults with COVID-19 disease	PLOS ONE
2022	Machine Learning-Derived Integer-Based Score and Prediction of Tertiary Hyperparathyroidism among Kidney Transplant Recipients: An Integer-Based Score to Predict Tertiary Hyperparathyroidism	CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
2022	Changing trends in gastric cancer incidence and mortality: the role of upper endoscopy in low-risk countries	ENDOSCOPY
2022	Optimal Rhythm Control Strategy in Patients With Atrial Fibrillation	KOREAN CIRCULATION JOURNAL
2022	Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases	CLINICAL AND MOLECULAR HEPATOLOGY
2022	The Korean Organ Transplantation Registry (KOTRY): an overview and summary of the kidney-transplant cohort	KIDNEY RESEARCH AND CLINICAL PRACTICE
2022	The Common and Unique Pattern of Microbiome Profiles among Saliva, Tissue, and Stool Samples in Patients with Crohn's Disease	MICROORGANISMS
2022	A phase 1b/2 study of PF-06747775 as monotherapy or in combination with Palbociclib in patients with epidermal growth factor receptor mutant advanced non-small cell lung cancer	EXPERT OPINION ON INVESTIGATIONAL DRUGS
2022	Ablation and antiarrhythmic drug effects on PITX2 +/- deficient atrial fibrillation: A computational modeling study	FRONTIERS IN CARDIOVASCULAR MEDICINE
2022	Lower pulmonary vein-to-left atrium volume ratio predicts poor rhythm outcome after atrial fibrillation catheter ablation	FRONTIERS IN CARDIOVASCULAR MEDICINE
2022	Altered Glucose Metabolism and Glucose Transporters in Systemic Organs After Bariatric Surgery	FRONTIERS IN ENDOCRINOLOGY
2022	Impact of COVID-19 on the HIV care continuum in Asia: Insights from people living with HIV, key populations, and HIV healthcare providers	PLOS ONE
2022	Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy	BLOOD